Alerts will be sent to your verified email
Verify Email
VAISHALI
|
Vaishali Pharma
|
Curis Lifesciences
|
Bharat Immunological
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.83 % | 76.73 % | 0.0 |
|
5yr average Equity Multiplier
|
2.48 | 1.91 | 3.08 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 1.07 | 0.61 |
|
5yr Avg Net Profit Margin
|
3.68 % | 8.37 % | -18.38 % |
|
Price to Book
|
1.16 | 4.56 | 0.91 |
|
P/E
|
0.0 | 12.1 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
87.63 Days | 45.79 Days | 206.63 Days |
|
Inventory Days
|
6.87 Days | 77.61 Days | 125.06 Days |
|
Days Receivable
|
177.19 Days | 65.45 Days | 61.4 Days |
|
Days Payable
|
159.49 Days | 245.93 Days | 117.81 Days |
|
5yr Average Interest Coverage Ratio
|
2.55 | 5.43 | -2.32 |
|
5yr Avg ROCE
|
15.65 % | 36.41 % | -44.64 % |
|
5yr Avg Operating Profit Margin
|
5.99 % | 16.92 % | -18.7 % |
|
5 yr average Debt to Equity
|
0.48 | 0.12 | 0.71 |
|
5yr CAGR Net Profit
|
-4.82 % | 65.64 % | 23.51 % |
|
5yr Average Return on Assets
|
3.24 % | 9.21 % | -10.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.61 % | n/a | 59.25 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.87 % | n/a | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Vaishali Pharma
|
Curis Lifesciences
|
Bharat Immunological
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|